Preliminary experience with neural response telemetry in the Nucleus CI24Mcochlear implant

Citation
Cj. Brown et al., Preliminary experience with neural response telemetry in the Nucleus CI24Mcochlear implant, AM J OTOL, 19(3), 1998, pp. 320-327
Citations number
9
Categorie Soggetti
Otolaryngology
Journal title
AMERICAN JOURNAL OF OTOLOGY
ISSN journal
01929763 → ACNP
Volume
19
Issue
3
Year of publication
1998
Pages
320 - 327
Database
ISI
SICI code
0192-9763(199805)19:3<320:PEWNRT>2.0.ZU;2-H
Abstract
Objective: This study aimed to compare recordings of the electrically evoke d whole nerve action potential (EAP) made using the reverse telemetry syste m of the Nucleus CI24M device with those recorded from individuals who use the Ineraid cochlear implant system. Study Design: Data were collected in a prospective fashion from Nucleus CI2 4M cochlear implant users and compared with retrospective data collected fr om patients who use the Ineraid device. Setting: All data were collected at the Department of Otolaryngology-Head a nd Neck Surgery, University of Iowa Hospitals and Clinics. Patients: Data are reported from 8 patients who use the Nucleus CI24M cochl ear implant and 20 patients who use the Ineraid cochlear implant system. Interventions: The interventions described in this study were diagnostic in nature. Main Outcome Measures: EAP growth and refractory recovery data are reported . EAP thresholds recorded from patients who use the Nucleus CI24M device al so are compared with behavioral thresholds for the stimulus used to evoke t he EAP as well as the stimulation levels needed to program the speech proce ssor. Results: EAP morphology, growth, and refractory recovery functions recorded using the Nucleus CI24M reverse telemetry system compared favorably with s imilar measures recorded from Ineraid cochlear implant users. Conclusions: Reasonable EAP responses can be recorded using the Nucleus CI2 4M device. More data are needed to determine whether the information about neural responsiveness available with this device will be clinically useful.